Director Share Purchase

RNS Number : 8123S
Craneware plc
14 March 2023
 

Craneware plc

("Craneware", "The Craneware Group", the "Company" or the "Group")

 Director Share Purchase

14 March 2023   -   Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, has been notified that on 13 March, Keith Neilson, CEO of the Company, purchased 3,484 ordinary shares of 1p each in the Company ("Ordinary Shares") at a price of 1435p per Ordinary share.

 

Following the purchase, Mr. Neilson   holds 3,446,539 Ordinary Shares in the capital of the Company, representing 9.7% of the Company's issued share capital.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:

1.  Details of the Restricted Person / person closely associated with him or her

 

a) Name

Keith Neilson



2.    Reason for the notification

 


a) Position / status

CEO

b) Initial notification / Amendment

Initial notification


 

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a) Name 

Craneware plc

b) LEI 

213800O2CTJ1YFXNXG05


 

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a) Description of the financial instrument, type of instrument 

Ordinary Shares of 1p each in the capital of Craneware plc

b) Identification code

ISIN GB00B2425G68

c) Nature of the transaction 

Purchase of Ordinary Shares

d) Price(s) and volume(s) 

Volume(s)  3484 Price(s) £14.35

e) Aggregated information:

  i. Aggregated volume

ii. Price

N/A (single transaction)

-

-

f) Date of the transaction

2023-03-13

g) Place of the transaction

London Stock Exchange (XLON)

 

 

For further information, please contact:  

 

Craneware plc

+44 (0)131 550 3100

Keith Neilson, CEO


Craig Preston, CFO




Alma (Financial PR)

+44 (0)20 3405 0205

Caroline Forde, Joe Pederzolli, Kinvara Verdon

craneware@almapr.co.uk



Peel Hunt (NOMAD and Joint Broker) 

+44 (0)20 7418 8900

Dan Webster, Andrew Clark




Investec Bank PLC (Joint Broker)

+44 (0)20 7597 5970

Patrick Robb, Henry Reast, Sebastian Lawrence



Berenberg (Joint Broker)

+44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Dan Gee-Summons


 

About Craneware

 

We at The Craneware Group of companies, including our latest additions Sentry Data Systems and Agilum Healthcare Intelligence, passionately believe we can impact healthcare profoundly by delivering the insights healthcare organisations need to also transform the business of healthcare. Our shared vision is to be the operational and financial partner for US healthcare providers.

 

Our combined suite of applications and industry-leading team of experts help our customers contextualise operational, financial, and clinical data, providing insights that clearly demonstrate what great looks like. These value cycle insights deliver revenue integrity and 340B compliance, as well as margin and operational intelligence - something no other single partner can provide.

 

Together, approximately 40% of registered US hospitals are now our customers, including more than 12,000 US hospitals, health systems and affiliated retail pharmacies and clinics. Our customers are operating with a financial impact of nearly half a trillion dollars. We have data sets from customers covering more than 150 million unique patients encounters.

 

Learn more at   www.thecranewaregroup.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGZGMFRFFGFZM

Companies

Craneware (CRW)
UK 100

Latest directors dealings